Antoine G. Dipsia, M.D.
NPI 1013093558ActiveIndividual· Family Medicine, Adult Medicine· W. Sacramento, CA
Family Medicine, Adult Medicine (M.D.) with Elica Health Centers, practicing in W. Sacramento, California. Their prescriptions cost Medicare Part D more than their services did: $678,321 for 2,929 claims, against $1,516 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 20 companies reporting payments in 2025, $5,008 in all, mostly food and beverage.
Overview
| NPI | 1013093558 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Oct 27, 2006 |
| Last updated in NPPES | Feb 8, 2010 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Family Medicine, Adult Medicine Primary | 207QA0505X | A40970 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Family Practice (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 126 |
|---|---|
| Services billed | 178 across 8 procedure codes |
| Paid by Medicare | $1,516 |
Part D prescriptions in 2024
| Prescriptions (claims) | 2,929 · 5,966 30-day fills |
|---|---|
| Patients | 215 |
| Total drug cost | $678,321 |
| Generic share | 78% of claims |
Education and affiliations
| Graduation year | 1977 |
|---|---|
| Medicare specialty | Family Practice |
Medical group
- Elica Health CentersSacramento, CA · 22 clinicians
Industry payments (Open Payments)
- 2025$5,008 · 104 payments from 20 companies
- 2024$3,344 · 79 payments from 18 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $566.91 | 7 |
| Abbvie Inc. | $511.88 | 25 |
| Amgen Inc. | $508.51 | 10 |
| Glaxosmithkline, LLC. | $480.94 | 10 |
| Novo Nordisk Inc | $472.63 | 12 |
What the 2025 payments were for
- Food and Beverage$5,008 · 104 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records